- Home
- ZOM vs RFAI Comparison
ZOM vs RFAI Comparison
Compare ZOM & RFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZOM
- RFAI
- Stock Information
- Founded
- ZOM 2015
- RFAI 2024
- Country
- ZOM United States
- RFAI Singapore
- Employees
- ZOM N/A
- RFAI N/A
- Industry
- ZOM Biotechnology: Pharmaceutical Preparations
- RFAI
- Sector
- ZOM Health Care
- RFAI
- Exchange
- ZOM Nasdaq
- RFAI NYSE
- Market Cap
- ZOM 135.9M
- RFAI 153.1M
- IPO Year
- ZOM N/A
- RFAI 2024
- Fundamental
- Price
- ZOM $0.13
- RFAI $10.18
- Analyst Decision
- ZOM
- RFAI
- Analyst Count
- ZOM 0
- RFAI 0
- Target Price
- ZOM N/A
- RFAI N/A
- AVG Volume (30 Days)
- ZOM 7.3M
- RFAI 14.0K
- Earning Date
- ZOM 11-07-2024
- RFAI 01-01-0001
- Dividend Yield
- ZOM N/A
- RFAI N/A
- EPS Growth
- ZOM N/A
- RFAI N/A
- EPS
- ZOM N/A
- RFAI N/A
- Revenue
- ZOM $26,727,000.00
- RFAI N/A
- Revenue This Year
- ZOM $36.75
- RFAI N/A
- Revenue Next Year
- ZOM $14.92
- RFAI N/A
- P/E Ratio
- ZOM N/A
- RFAI N/A
- Revenue Growth
- ZOM 11.33
- RFAI N/A
- 52 Week Low
- ZOM $0.12
- RFAI $10.00
- 52 Week High
- ZOM $0.23
- RFAI $10.27
- Technical
- Relative Strength Index (RSI)
- ZOM 51.79
- RFAI N/A
- Support Level
- ZOM $0.12
- RFAI N/A
- Resistance Level
- ZOM $0.16
- RFAI N/A
- Average True Range (ATR)
- ZOM 0.01
- RFAI 0.00
- MACD
- ZOM 0.00
- RFAI 0.00
- Stochastic Oscillator
- ZOM 33.95
- RFAI 0.00
About ZOM Zomedica Corp.
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.
About RFAI RF ACQUISITION CORP II
RF Acquisition Corp II is a blank check company.